| Customization: | Available |
|---|---|
| Varieties: | Parasite Disease Prevention Medicine |
| Component: | Chemical Synthetic Drugs |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Action and use: Anti-anemia drugs.
For iron deficiency anaemia in foals, calves, piglets, puppies and fur animals.
Administration: Intramuscular injection.
Withdrawal period: No
Packing: 50ml/vial, 100ml/vial
Certificate: ISO9001, GMP
OEM & ODM Service.
| Specification | Company Standard | Usage | Iron supplement |
| Raw Material | Iron dextran | Species | Cattle, sheep, swine,chicken |
| Dosage Form | injection | Sample | Yes |
| Packing | 100ml | Delivery Time | 30days |
| MOQ | 500kg | Payment Term | T/T, D/P, D/A, L/C |
| GMP | Yes | ISO9001 | Yes |
| FDA | / | COS | / |
Pharmacodynamics: Iron is the main component of hemoglobin and myoglobin. Hemoglobin is the main oxygen carrier in red blood cells. Myoglobin is the site where muscle cells store oxygen to help supply oxygen during muscle exercise. Most enzymes and factors implicated in the tricarboxylic acid cycle contain iron, or can only function in the presence of iron. Therefore, after active iron supplementation in iron-deficient animals, in addition to accelerated hemoglobin synthesis, symptoms related to tissue iron deficiency and decreased iron-containing enzyme activity such as growth retardation, behavioral abnormalities, and physical deficiency can be gradually corrected. Pharmacokinetics Iron for injection, which is absorbed more rapidly than orally; plasma concentrations peak at 24 ∼ 48 hours after intramuscular injection of iron dextran, i.e.
Iron dextran molecules are large, absorbed by lymphatic vessels and then transferred to the blood, and the plasma concentration increases slowly; after injection into the blood circulation or intramuscular injection, they are phagocytosed and decomposed into iron and dextran by the monocyte-phagocyte system. After absorption, iron ions are oxidized by ceruloplasmin in the blood to trivalent iron ions, which then bind to transferrin receptor and enter the cells in the form of pinocytosis for hematopoietic cells. They can also accumulate in the liver, spleen, bone marrow and other monocyte-phagocyte systems in the form of ferritin or hemosiderin. Protein binding is high in hemoglobin, low in myoglobin, enzymes, and iron-transporting proteins, and low in ferritin or hemosiderin.
Anti-anemia drugs. For iron deficiency anaemia in foals, calves, piglets, puppies and fur animals.
Intramuscular injection: a single dose, 4 ~ 12ml for foals and calves; 2 ~ 4ml for piglets; 0.4 ~ 4ml for puppies; 1 ~ 4ml for foxes; 0.6 ~ 2ml for mink.
Piglets injected with iron occasionally experience unstable standing due to muscle weakness, which can cause death in severe cases.
(1)This product has greater toxicity and requires strict control of intramuscular injection dose.
(2)Intramuscular injection can cause local pain and should be injected deep into the muscle.
(3)Injection in pigs older than 4 weeks of age can cause staining of the gluteal muscles.
(4)It needs to be protected from freezing, and precipitation can occur after a long time.
Iron salts can react with many chemicals or drugs, so they should not be administered simultaneously or mixed orally with other drugs.
Does not need to be developed.
Protect from light.
Company Profile
Hebei Veyong pharmaceutical Co., Ltd, was established in 2002, located in Shijiazhuang City, Hebei Province, China, next to the Capital Beijing. She is a large GMP-certified veterinary drug enterprise, with R&D, production and sales of veterinary APIs, preparations, premixed feeds and feed additives. As Provincial Technical Center, Veyong has established an innovated R&D system for new veterinary drug, and is the nationally known technological innovation-based veterinary enterprise, there are 65 technical professionals. Veyong has two production bases: Shijiazhuang and Ordos, of which the Shijiazhuang base covers an area of 78,706 m2, with 13 API products including Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, and 12 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant, ects. Veyong provides APIs, more than 100 own-label preparations, and OEM & ODM service.
Veyong attaches great importance to the management of EHS(Environment, Health& Safety) system, and obtained the ISO14001 and OHSAS18001 certificates. Veyong has been listed in the strategic emerging industrial enterprises in Hebei Province and can ensure the continuous supply of products.
Veyong established the complete quality management system, obtained the ISO9001 certificate, China GMP certificate, Australia APVMA GMP certificate, Ethiopia GMP certificate, Ivermectin CEP certificate, and passed US FDA inspection. Veyong has professional team of registeration, sales and technical service, our company has gained reliance and support from numerous customers by excellent product quality, high-quality pre-sales and after-sales service, serious and scientific managemen. Veyong has made long term cooperation with many internationally known animal pharmaceutical enterprises with products exported to the Europe, South America, Middle East, Africa, Asia, etc. more than 60 countries and regions.
Veyong takes "Maintain animal health, improve quality of life" as the mission, strives to become the most valuable veterinary drug brand, and looks forward to active cooperation with global customers.
){kind=link}